Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Lyden P, Pryor KE, Coffey CS, Cudkowicz M, et al. Final Results of the RHAPSODY trial: A multi-center, Phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a Recombinant Variant of Human Activated Protein C, in combination with tissue plasminogen a Ann Neurol 2018 Nov 18. doi: 10.1002/ana.25383.
PMID: 30450637


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016